ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+33.35%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$2.59B
AUM Growth
+$2.59B
(+24%)
Cap. Flow
+$246M
Cap. Flow
% of AUM
9.48%
Top 10 Holdings %
Top 10 Hldgs %
62.95%
Holding
64
New
12
Increased
9
Reduced
11
Closed
21
Top Buys
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$137M |
| 2 |
Sarepta Therapeutics
SRPT
|
$127M |
| 3 |
PTC Therapeutics
PTCT
|
$77.4M |
| 4 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$71.7M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$69M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$83.4M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$48.1M |
| 3 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
$45.2M |
| 4 |
Dynavax Technologies
DVAX
|
$32.8M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
$31.4M |
Sector Composition
| 1 | Healthcare | 81.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $419M | 16.14% | 17,714,461 +775,000 | +5% | +$18.3M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $237M | 9.11% | 4,798,101 +400,000 | +9% | +$19.7M |
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $153M | 5.88% | 1,622,770 -88,225 | -5% | -$8.31M |
|
4
Amicus Therapeutics
FOLD
$2.34B
| $146M | 5.63% | 9,369,150 -136,297 | -1% | -$2.13M |
|
5
Ascendis Pharma
ASND
$11.8B
| $137M | 5.28% | 2,063,336 | – | – |
|
|
6
Madrigal Pharmaceuticals
MDGL
$9.76B
| $137M | 5.27% | +489,536 | New | +$137M |
|
|
7
Sarepta Therapeutics
SRPT
$1.78B
| $127M | 4.88% | +958,928 | New | +$127M |
|
8
Iovance Biotherapeutics
IOVA
$807M
| $105M | 4.03% | 8,177,720 +99,215 | +1% | +$1.27M |
|
|
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $92.6M | 3.57% | 5,593,683 +435,000 | +8% | +$7.2M |
|
|
ECYT
10
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $78.6M | 3.03% | 5,695,200 | – | – |
|
|
11
PTC Therapeutics
PTCT
$3.92B
| $77.4M | 2.98% | +2,294,877 | New | +$77.4M |
|
|
SPPI
12
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $71.7M | 2.76% | +3,419,818 | New | +$71.7M |
|
|
13
Alnylam Pharmaceuticals
ALNY
$58.5B
| $69M | 2.65% | +700,100 | New | +$69M |
|
|
ZGNX
14
DELISTED
Zogenix, Inc.
ZGNX
| $66.4M | 2.56% | 1,503,313 +314,100 | +26% | +$13.9M |
|
15
TG Therapeutics
TGTX
$4.65B
| $65.1M | 2.51% | 4,950,031 -279,588 | -5% | -$3.68M |
|
16
argenx
ARGX
$43.6B
| $64.8M | 2.49% | 782,053 -81,222 | -9% | -$6.73M |
|
17
Puma Biotechnology
PBYI
$254M
| $61.2M | 2.36% | 1,034,375 +209,007 | +25% | +$12.4M |
|
18
Vanda Pharmaceuticals
VNDA
$279M
| $53.3M | 2.05% | 2,800,191 +25,000 | +0.9% | +$476K |
|
|
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
| $52.1M | 2.01% | 1,146,436 -19,448 | -2% | -$884K |
|
20
Pacira BioSciences
PCRX
$1.2B
| $46.8M | 1.8% | 1,460,610 -254,462 | -15% | -$8.16M |
|
21
Viking Therapeutics
VKTX
$3.04B
| $42.4M | 1.63% | +4,471,300 | New | +$42.4M |
|
22
Assembly Biosciences
ASMB
$190M
| $37.8M | 1.45% | 963,427 -130,507 | -12% | -$5.12M |
|
|
MDCO
23
DELISTED
Medicines Co
MDCO
| $35.3M | 1.36% | 961,574 -674,243 | -41% | -$24.7M |
|
|
TCDA
24
DELISTED
Tricida, Inc. Common Stock
TCDA
| $32.8M | 1.26% | +1,095,764 | New | +$32.8M |
|
|
GBT
25
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $31.7M | 1.22% | 700,548 -1,065,000 | -60% | -$48.1M |
|